Press Release
Lipitor, Seroquel and Ambien CR Web Sites Rank Highest for Ease of Use, Content Quality
Report Assesses Degree to Which Pharma Sites Connect With Consumers Online
New York, NY (PRWEB) September 23, 2009 -- Leading web researchers Change Sciences Group today released an all new research report that ranks prescription drug web sites for ease of use, content quality and persuasiveness. Sites are compared using an advanced technology called Kantuit UX Compare, providing data on site effectiveness. The data is new to the pharmaceutical industry.
To jump to details about the report visit: www.changesciences.com/pharma.
"Consumers use prescription drug web sites to meet real needs. Whether it?s a mom seeking treatment information for a sick child or an allergy sufferer seeking relief, Pharmaceutical companies have a real opportunity to connect online with people they can truly help" said Steve Ellis, a Change Sciences partner.
Data highlights include the following.
- 20% of sites have page layout problems that make information hard to find for a significant number of users
- 60% of sites fail to answer at least one question that most users have
- 33% of sites have instances of visual design that are perceived by many users to be less than professional
- 93% of sites lack some content that some users consider persuasive
The top three performers overall are: Lipitor, Seroquel and Ambien CR.
Other sites included in the research are: Abilify, Actos, Advair Diskus, Ambien CR, Celebrex, Cymbalta, Effexor XR, Lexapro, Nexium, Plavix, Prevacid, Seroquel, Singulair, and Vyotrin.
For more details about the report, including the complete site rankings, more findings, sample data, and methodology visit: http://changesciences.com/pharma.
About Change Sciences Group
Change Sciences was founded in January 2000 to help business, government and non-profit organizations match web development to user needs. Clients include some of the world?s most innovative organizations, including the United States Department of Agriculture and Bank of America.
Contact:
Media
Change Sciences Group, Inc.
888-864-1160 x731
www.changesciences.com